Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic strategy for managing metabolic syndromes. These naturally occurring molecules are secreted by the gut in response to food intake, https://brightbookmarks.com/story20667883/unveiling-the-therapeutic-potential-of-glp-1-peptides